Colgate-Palmolive remains a Buy, offering defensive qualities, a resilient global portfolio, and an attractive margin of ...

Two of the market’s most reliable dividend payers just cut checks to shareholders within days of each other. Procter & Gamble ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Colgate-Palmolive stock (NYSE: CL) has gained 40% in value since early January 2023 – jumping from levels of around $75 then to over $105 now – vs. an increase of about 45% for the S&P 500 over this ...

Colgate-Palmolive serves global consumer markets across oral care, home care, personal care and pet nutrition within the S&P ...

A 15% year-to-date loss at a time when broader benchmarks are flirting with all-time highs may be enough to cause some investors to write off Colgate-Palmolive, but there are some sparks that could ...

Colgate-Palmolive stock (ISIN US1845021021) is currently quoted at 77.78 EUR on the Stuttgart Exchange as of September 4, ...

Consumer goods manufacturer Colgate-Palmolive (NYSE:CL) reported mixed fourth-quarter and full-year 2024 earnings on Friday, Jan. 31. Adjusted earnings per share (EPS) for Q4 rose to $0.91, surpassing ...

Colgate-Palmolive Company reported Q1 results, showing relatively stable underlying sales. The consumer environment remains cautious, causing pressure in some markets and a more cautious underlying ...

Colgate-Palmolive India names former executive Manish Anandani as MD and CEO, replacing Prabha Narasimhan, who moves to an APAC marketing role after four years at the helm.